Bioreducible PEI-siRNA nanocomplex for liver cancer therapy: Transfection, biodistribution, and tumor growth inhibition in vivo

Journal of Nanomaterials

Volumn 2013, Issue , 2013, Pages

  Xia, Wei ^a,b   Li, Yan ^a   Lou, Bo ^a,c   Wang, Peijun ^a   Gao, Xiaolong ^a   Lin, Chao ^c  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; GOLD STANDARDS; HEPG2 CELLS; IN-VITRO; IN-VIVO; LIVER CANCERS; MOUSE MODELS; NANOCOMPLEXES; NON-VIRAL GENE DELIVERY; NONVIRAL; PLASMID DNA; POLYETHYLENIMINES; POSITIVE SURFACE CHARGE; TUMOR GROWTH;

GENE TRANSFER; NUCLEIC ACIDS; TUMORS;

GOLD COMPOUNDS;

EID: 84873381291     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2013/384717     Document Type: Article

References (27)

1. Lau W. Y., Primary liver tumors. Seminars in Surgical Oncology 2000 19 2 135 144
2. Okuda K., Hepatocellular carcinoma. Journal of Hepatology 2000 32 1 225 237 2-s2.0-0034090264 (Pubitemid 30123637)
3. Ng I. O. L., Poon R. T. P., Lee J. M. F., Fan S. T., Ng M., Tso W. K., Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. American Journal of Clinical Pathology 2001 116 6 838 845 2-s2.0-0035190559 10.1309/FXNL-QTN1-94FH-AB3A (Pubitemid 33108154)
4. Yamaguchi R., Yano H., Iemura A., Ogasawara S., Haramaki M., Kojiro M., Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 1998 28 1 68 77 2-s2.0-0031807538 10.1002/hep.510280111 (Pubitemid 28299987)
5. Gerber H. P., Dixit V., Ferrara N., Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. Journal of Biological Chemistry 1998 273 21 13313 13316 2-s2.0-0032557564 10.1074/jbc.273.21.13313 (Pubitemid 28246905)
6. Takahashi T., Ueno H., Shibuya M., VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 1999 18 13 2221 2230 2-s2.0-0033118228 (Pubitemid 29186923)
7. Shibuya M., Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Structure and Function 2001 26 1 25 35 2-s2.0-0035003384 10.1247/csf.26.25 (Pubitemid 32421949)
8. Devi G. R., siRNA-based approaches in cancer therapy. Cancer Gene Therapy 2006 13 9 819 829 2-s2.0-33747226732 10.1038/sj.cgt.7700931
9. Jeong J. H., Christensen L. V., Yockman J. W., Zhong Z., Engbersen J. F. J., Jong Kim W., Feijen J., Wan Kim S., Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 2007 28 10 1912 1917 2-s2.0-33846302477 10.1016/j.biomaterials.2006.12.019 (Pubitemid 46123547)
10. Raskopf E., Vogt A., Sauerbruch T., Schmitz V., siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. Journal of Hepatology 2008 49 6 977 984 2-s2.0-55549120187 10.1016/j.jhep.2008.07.022
11. Oh Y. K., Park T. G., siRNA delivery systems for cancer treatment. Advanced Drug Delivery Reviews 2009 61 10 850 862 2-s2.0-67649295505 10.1016/j.addr.2009.04.018
12. Gary D. J., Puri N., Won Y. Y., Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. Journal of Controlled Release 2007 121 1-2 64 73 2-s2.0-34547228805 10.1016/j.jconrel.2007.05.021 (Pubitemid 47126065)
13. Boyer C., Priyanto P., Davis T. P., Pissuwan D., Bulmus V., Kavallaris M., Teoh W. Y., Amal R., Carroll M., Woodward R., St Pierre T., Anti-fouling magnetic nanoparticles for siRNA delivery. Journal of Materials Chemistry 2010 20 2 255 265 2-s2.0-72549101170 10.1039/b914063h
14. Boussif O., Lezoualch F., Zanta M. A., Mergny M. D., Scherman D., Demeneix B., Behr J. P., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 1995 92 16 7297 7301 2-s2.0-0029160083 10.1073/pnas.92.16.7297
15. Xia W., Wang P., Lin C., Li Z., Gao X., Wang G., Zhao X., Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo. Journal of Controlled Release 2012 157 3 427 436
16. Xia W., Lin C., Bioreducible polymer-delivered siRNA targeting human telomerase reverse transcriptase for human cancer gene therapy. Therapeutic Delivery 2012 3 4 439 442
17. Lin C., Engbersen J. F. J., PEGylated bioreducible poly(amido amine)s for non-viral gene delivery. Materials Science and Engineering C 2011 31 7 1330 1337
18. Sun Y. Y., Deng Z. F., Tian Y., Lin C., Horseradish peroxidase-mediated in situ forming hydrogels from degradable tyramine-based poly(amido amine)s. Journal of Applied Polymer Science 2013 127 1 40 48
19. Lin C., Ge J. P., Multifunctional polyethylenimine-conjugated superparamagnetic nanoparticles for drug delivery and imaging. Journal of Controlled Release 2011 152 supplement 1 e58 e60
20. Li F., Ba Q. J., Niu S. M., Guo Y., Duan Y. K., Zhao P., Lin C., Sun J., In-situ forming biodegradable glycol chitosan-based hydrogels: synthesis, characterization, and chondrocyte culture. Materials Science & Engineering C 2012 32 7 2017 2025
21. Lin C., Engbersen J. F. J., The role of the disulfide group in disulfide-based polymeric gene carriers. Expert Opinion on Drug Delivery 2009 6 4 421 439 2-s2.0-67649135738 10.1517/17425240902878010
22. Lin C., Zhong Z., Lok M. C., Jiang X., Hennink W. E., Feijen J., Engbersen J. F. J., Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjugate Chemistry 2007 18 1 138 145 2-s2.0-33846452896 10.1021/bc060200l (Pubitemid 46146003)
23. Lin C., Blaauboer C.-J., Timoneda M. M., Lok M. C., van Steenbergen M., Hennink W. E., Zhong Z., Feijen J., Engbersen J. F. J., Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. Journal of Controlled Release 2008 126 2 166 174 2-s2.0-39049157310 10.1016/j.jconrel.2007.11.012
24. Lin C., Zhong Z. Y., Lok M. C., Jiang X., Hennink W. E., Feijen J., Engbersen J. F. J., Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. Journal of Controlled Release 2006 116 2 130 137 2-s2.0-33845307269 10.1016/j.jconrel.2006.09.009 (Pubitemid 44872912)
25. Plank C., Mechtler K., Szoka F. C., Wagner E., Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Human Gene Therapy 1996 7 12 1437 1446 2-s2.0-0029789793 (Pubitemid 26293564)
26. Son S., Singha K., Kim W. J., Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials 2010 31 24 6344 6354 2-s2.0-77953651230 10.1016/j.biomaterials.2010.04.047
27. Son S., Kim W. J., Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Biomaterials 2010 31 1 133 143 2-s2.0-70350542589 10.1016/j.biomaterials.2009.09.024